Table of Contents for the Digital Edition of BioPharm International - November 2007 BioPharm International - November 2007 Contents From the Editor Global News Regulatory Beat China Today What Follow-on Biologics Mean for the Future of the Biotechnology Industry Engineering Biopharmaceuticals A History of the OOS Problem Final Word BioPharm International - November 2007 BioPharm International - November 2007 - BioPharm International - November 2007 (Page 1) BioPharm International - November 2007 - BioPharm International - November 2007 (Page 2) BioPharm International - November 2007 - BioPharm International - November 2007 (Page 3) BioPharm International - November 2007 - Contents (Page 4) BioPharm International - November 2007 - Contents (Page 5) BioPharm International - November 2007 - Contents (Page 6) BioPharm International - November 2007 - Contents (Page 7) BioPharm International - November 2007 - From the Editor (Page 8) BioPharm International - November 2007 - From the Editor (Page 9) BioPharm International - November 2007 - Global News (Page 10) BioPharm International - November 2007 - Global News (Page 11) BioPharm International - November 2007 - Regulatory Beat (Page 12) BioPharm International - November 2007 - Regulatory Beat (Page 13) BioPharm International - November 2007 - Regulatory Beat (Page 14) BioPharm International - November 2007 - China Today (Page 15) BioPharm International - November 2007 - China Today (Page 16) BioPharm International - November 2007 - China Today (Page 17) BioPharm International - November 2007 - What Follow-on Biologics Mean for the Future of the Biotechnology Industry (Page 18) BioPharm International - November 2007 - What Follow-on Biologics Mean for the Future of the Biotechnology Industry (Page 19) BioPharm International - November 2007 - What Follow-on Biologics Mean for the Future of the Biotechnology Industry (Page 20) BioPharm International - November 2007 - What Follow-on Biologics Mean for the Future of the Biotechnology Industry (Page 21) BioPharm International - November 2007 - What Follow-on Biologics Mean for the Future of the Biotechnology Industry (Page 22) BioPharm International - November 2007 - What Follow-on Biologics Mean for the Future of the Biotechnology Industry (Page 23) BioPharm International - November 2007 - What Follow-on Biologics Mean for the Future of the Biotechnology Industry (Page 24) BioPharm International - November 2007 - Engineering Biopharmaceuticals (Page 25) BioPharm International - November 2007 - Engineering Biopharmaceuticals (Page 26) BioPharm International - November 2007 - Engineering Biopharmaceuticals (Page 27) BioPharm International - November 2007 - Engineering Biopharmaceuticals (Page 28) BioPharm International - November 2007 - Engineering Biopharmaceuticals (Page 29) BioPharm International - November 2007 - Engineering Biopharmaceuticals (Page 30) BioPharm International - November 2007 - A History of the OOS Problem (Page 31) BioPharm International - November 2007 - A History of the OOS Problem (Page 32) BioPharm International - November 2007 - A History of the OOS Problem (Page 33) BioPharm International - November 2007 - A History of the OOS Problem (Page 34) BioPharm International - November 2007 - A History of the OOS Problem (Page 35) BioPharm International - November 2007 - A History of the OOS Problem (Page 36) BioPharm International - November 2007 - A History of the OOS Problem (Page 37) BioPharm International - November 2007 - Final Word (Page 38) BioPharm International - November 2007 - Final Word (Page 39) http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.